Trump Administration Decides Not to End PBM Rebates

The Trump administration has decided not to pursue a policy that would have put an end to rebates paid to pharmacy benefit managers, which could put the focus again on how drug companies set their prices. The proposal would have barred drug companies from paying rebates to PBMs that participate in Medicare and other government [...]

By | 2019-10-03T12:48:13-07:00 October 3rd, 2019|Uncategorized|0 Comments

The Debate about PBM Rebates Continues

What started out as a way to help many pharmacy benefit managers (PBMs) to control costs has turned into a major sticking point in the health care system: pharmaceutical rebates. Attention is growing regarding the role that rebates play in actually increasing the price of brand-name drugs, which is adding a heavier burden on health [...]

By | 2019-03-26T08:32:18-07:00 March 26th, 2019|Healthcare|0 Comments